Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.

[1]  J. Ajani,et al.  Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Joon-Oh Park,et al.  Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Putter,et al.  Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) , 2011, BMC Cancer.

[4]  C. Willett,et al.  Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Giatromanolaki,et al.  Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study. , 2010, International journal of radiation oncology, biology, physics.

[6]  D. Cunningham,et al.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  M. Verheij,et al.  Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  G. Fountzilas,et al.  A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer , 2010, Cancer Chemotherapy and Pharmacology.

[9]  A. Carrato,et al.  Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. , 2009, International journal of radiation oncology, biology, physics.

[10]  M. Tez,et al.  External validation of a US-derived nomogram that predicts individual survival after gastric cancer resection , 2009, Langenbeck's Archives of Surgery.

[11]  J. Ajani,et al.  Chemoradiation of resected gastric cancer: A 10-year follow-up of the phase III trial INT0116 (SWOG 9008). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Willett,et al.  Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  K. Kozak,et al.  The survival impact of the intergroup 0116 trial on patients with gastric cancer. , 2008, International journal of radiation oncology, biology, physics.

[14]  H. Bartelink,et al.  A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. , 2007, International journal of radiation oncology, biology, physics.

[15]  Yasuo Ohashi,et al.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. , 2007, The New England journal of medicine.

[16]  H. Bartelink,et al.  Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy , 2007, British Journal of Cancer.

[17]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[18]  M. Kattan,et al.  Predicting Individual Survival After Gastric Cancer Resection: Validation of a U.S.-Derived Nomogram at a Single High-Volume Center in Europe , 2006, Annals of surgery.

[19]  C. Bokemeyer,et al.  Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Cornelis J H van de Velde,et al.  Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma , 2005, Cancer.

[21]  M. Kattan,et al.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Aller,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.

[23]  S. Hundahl,et al.  The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy , 2000, Cancer.

[24]  P. Engstrom,et al.  Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. O'fallon,et al.  Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[27]  P. Schein,et al.  A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma , 1982, Cancer.

[28]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[29]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[30]  J. Marsh,et al.  The concept of locally advanced gastric cancer: Effect of treatment on outcome , 1990, Cancer.